» Articles » PMID: 35940589

Two Years into the COVID-19 Pandemic: Lessons Learned

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan, China, causing a respiratory disease called coronavirus disease 2019 (COVID-19), which has massively impacted global public health and caused widespread disruption to daily life. The crisis caused by COVID-19 has mobilized scientists and public health authorities across the world to rapidly improve our knowledge about this devastating disease, shedding light on its management and control, and spawned the development of new countermeasures. Here we provide an overview of the state of the art of knowledge gained in the last 2 years about the virus and COVID-19, including its origin and natural reservoir hosts, viral etiology, epidemiology, modes of transmission, clinical manifestations, pathophysiology, diagnosis, treatment, prevention, emerging variants, and vaccines, highlighting important differences from previously known highly pathogenic coronaviruses. We also discuss selected key discoveries from each topic and underline the gaps of knowledge for future investigations.

Citing Articles

Effectiveness of SARS-CoV-2 testing strategies.

Saif-Ur-Rahman K, Nurdin N, Movsisyan A, Kothari K, Conway T, Tierney M Cochrane Database Syst Rev. 2025; 2:CD016192.

PMID: 39991854 PMC: 11848964. DOI: 10.1002/14651858.CD016192.


Evaluation of a Commercial Rapid Molecular Point-of-Care Assay for Differential Diagnosis Between SARS-CoV-2 and Flu A/B Infections in a Pediatric Setting.

Bottino P, Massarino C, Leli C, Scomparin E, Bara C, Gotta F Viruses. 2024; 16(10).

PMID: 39459970 PMC: 11512318. DOI: 10.3390/v16101638.


An Outbreak of Acute Hemorrhagic Conjunctivitis Caused by Coxsackievirus A24 in Eastern Uttar Pradesh, India 2023.

Behera S, Mishra N, Yadav R, Shukla A, Kumari M, Rajput S Intervirology. 2024; 67(1):106-113.

PMID: 39437765 PMC: 11524537. DOI: 10.1159/000540952.


Chronic Obstructive Pulmonary Disease and the Omicron Variant of COVID-19 Prognosis: A Retrospective Cohort Study.

Leung C, Yu E, Chan Y, Ho M, Kwok C, Chan H Cureus. 2024; 16(7):e65713.

PMID: 39211713 PMC: 11358666. DOI: 10.7759/cureus.65713.


Rare host variants in ciliary expressed genes contribute to COVID-19 severity in Bulgarian patients.

Kamenarova K, Kachakova-Yordanova D, Baymakova M, Georgiev M, Mihova K, Petkova V Sci Rep. 2024; 14(1):19487.

PMID: 39174791 PMC: 11341789. DOI: 10.1038/s41598-024-70514-3.


References
1.
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y . Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020; 71(16):2027-2034. PMC: 7184337. DOI: 10.1093/cid/ciaa344. View

2.
Billah M, Miah M, Khan M . Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence. PLoS One. 2020; 15(11):e0242128. PMC: 7657547. DOI: 10.1371/journal.pone.0242128. View

3.
Te Velthuis A, Arnold J, Cameron C, van den Worm S, Snijder E . The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent. Nucleic Acids Res. 2009; 38(1):203-14. PMC: 2800238. DOI: 10.1093/nar/gkp904. View

4.
Dejnirattisai W, Zhou D, Supasa P, Liu C, Mentzer A, Ginn H . Antibody evasion by the P.1 strain of SARS-CoV-2. Cell. 2021; 184(11):2939-2954.e9. PMC: 8008340. DOI: 10.1016/j.cell.2021.03.055. View

5.
Shang J, Han N, Chen Z, Peng Y, Li L, Zhou H . Compositional diversity and evolutionary pattern of coronavirus accessory proteins. Brief Bioinform. 2020; 22(2):1267-1278. PMC: 7665327. DOI: 10.1093/bib/bbaa262. View